Search Results 251-260 of 17796 for Coagulate

1. https://www.mayoclinic.org/chinese_organization_concepts.xml

2. Bentracimab (PB2452) in Ticagrelor-treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure - Mayo Clinic

   (coagulation factor Xa (recombinant), inactivated-zhzo). Note: Other protocol defined Inclusion/Exclusion criteria may apply. Eligibility last updated 9/27 ...

3. Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC) - Mayo Clinic

   Adequate hematologic, renal, hepatic, and coagulation function; Negative serum pregnancy test for female subjects with reproductive potential, and agreement ...

4. Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer - Mayo Clinic

   Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects; AIDS based on current Centers for Disease Control (CDC) definition; Grade 3-4 ...

5. A Study of the Safety of Joint Injected Sc-rAAV2.5IL-1Ra (a Virus Carried Gene Therapy) in Patients with Moderate Knee Osteoarthritis - Mayo Clinic

   Coagulation disorder. Patients with unstable knees. Temperature above 99.5° F. Identification as a member of a vulnerable population. BMI greater than 40 ...

6. Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma - Mayo Clinic

   Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects; note, however, that laboratory tests for coagulation parameters are not ...

7. A Study of Whole-Brain Radiation Therapy with or without Avoiding the Hippocampus while Treating Patients with Limited or Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects; Chronic obstructive pulmonary disease exacerbation or other respiratory ...

8. Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations - Mayo Clinic

   Adequate coagulation function as defined by either of the following criteria: International normalized ratio (INR) ≤ 1.5 x ULN; For subjects receiving ...

9. A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma - Mayo Clinic

   The participant has an adequate coagulation function as defined by International Normalized Ratio ≤1.5 or prothrombin time ≤1.5×ULN, and partial ...

10. An After Approval Study of the CardioMEMS Heart Failure System - Mayo Clinic

    Known coagulation disorders; Hypersensitivity or allergy to aspirin, and/or clopidogrel. Participating Mayo Clinic locations. Study statuses change often ...